OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2022
(3)
2015
(3)
2011
(3)
2019
(2)
2025
(1)
2024
(1)
2021
(1)
2013
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Results of the two incidence screenings in the National Lung Screening Trial.
Not available
S-EPMC4307922
|
biostudies-literature
Cite
Primum non nocere: a call for balance when reporting on CTE.
Not available
S-EPMC6594011
|
biostudies-literature
Cite
Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
Not available
S-EPMC4624003
|
biostudies-literature
Cite
Identification of common genetic risk variants for autism spectrum disorder.
Not available
S-EPMC6454898
|
biostudies-literature
Cite
Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited.
Not available
S-EPMC3286387
|
biostudies-literature
Cite
Mapping genomic loci implicates genes and synaptic biology in schizophrenia.
Not available
S-EPMC9392466
|
biostudies-literature
Cite
Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors.
Not available
S-EPMC8851871
|
biostudies-literature
Cite
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Not available
S-EPMC4321445
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders.
Not available
S-EPMC8458480
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets